skip to main
|
skip to sidebar
Xcovery blog - kinase industry knowledge collected and sometimes analyzed
Wednesday, January 03, 2007
Collection of good alliance articles, courtesy of Kaufmann eVenturing
Five Strategies for Partnering with Larger Companies
Evaluating and Selecting a Strategic Partner
Top Ten Questions about Biotech Strategic Alliances
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Kinase Industry Biz News
Links
Multi-targeted Therapy
All things chromatin
Guide to biotech IP
IHOP - great protein db
Kinase research portal
Seeking Alpha - solid biotech investment insight
Decent but dated summary of kinase therapeutics
Biotech licensing blog
Research VEGF
Therapeutic Angiogenesis
Xcovery
Email Tim (sitehost)
Blog Roll
KinasePro
Bio Health Investor
Biotechnology Stocks
In the pipeline
Omics! Omics!
On Bio VC
Org Prep Daily (home of Milkshake)
The Curious Waveform
Tim's Personal Blog
Totally Medicinal
Whistling in the Wind
Cool liks
Pfizer's RTK animation
ArQule's c-Met animation
Kinase efforts you may not know of
Calistoga Pharma (PI-3 p110 delta)
Semafore (PI3)
KAI Pharma (PKC-delta)
Locus (p38 & unnamed multi-TK)
Pharmacyclics (Btk)
Coratus
Tigris Pharmaceuticals
Blog Archive
►
2012
(1)
►
March
(1)
▼
2007
(33)
►
March
(5)
►
February
(8)
▼
January
(20)
DNA making big immunology bet
Interesting story of Scios' CEO and p38 program
Top 100 2006 Publications
Way cool kinase target popularity charts
Why drugs fall short in late-stage trials
Tarceva: running in place?
Aurora
DNA keeps rolling (4Q earnings)
Sutent now a first line therapy for RCC in Europe
Cancer death rate falls again!
Speaking of Gleevec....
Targeted therapies: 2006 and beyond
BoA likes Array
Curious deal....(Amphora to Genentech)
1st Xcovery appearance in media.....
Correction: Omnitarg: not so much
Quick hits
Pop. media: cancer drugs lead to sea change in pharma
Collection of good alliance articles, courtesy of ...
Exelixis is like butter.....
►
2006
(54)
►
December
(5)
►
November
(34)
►
October
(15)
Google search
Web
xcovery.blogspot.com
Sitemeter
Technorati
clustermap
Cloud
Labels
2007
(1)
ABT-737
(1)
Accelrys
(1)
access
(1)
Akt
(2)
ALL
(2)
Alliances
(1)
Ambit
(1)
AMG 706
(2)
AMGN
(1)
AML
(1)
Amphora
(1)
Ariad
(1)
ARRY
(4)
ARRY-543
(1)
ARRY-797
(1)
Arxxant
(1)
Aurora
(2)
Avastin
(3)
Aveon
(1)
Axitinib
(1)
Axl
(1)
AZ
(1)
basics
(1)
Bayer
(2)
Bcr-abl
(1)
BI
(1)
BI-2536
(1)
BIBF-1120
(1)
BIBW-2992
(1)
Biomira
(1)
BMS
(4)
BREL
(1)
business models
(1)
cancer
(2)
CDK4
(2)
Celebrex
(1)
Cephalon
(1)
CGI
(1)
chemo
(1)
CML
(1)
CML NVS
(1)
cool
(2)
Cox-2
(1)
CP-690550
(1)
CP-751871
(1)
Curagen
(1)
CYC116
(1)
Cyclacel
(3)
discovery
(1)
DNA
(10)
EGFR
(3)
erb-b2
(2)
Exelixis
(2)
finance
(1)
Flt-3
(1)
Gleevec
(5)
GSK
(2)
HDI
(1)
herceptin
(2)
Icahn
(1)
IGFR-1
(1)
IKK
(1)
IMC-3G3
(1)
IMCL
(4)
inflammation
(1)
Innovive
(1)
IPO
(1)
Iressa
(1)
IVGN
(1)
JAK2
(1)
Jak3
(2)
Kit
(1)
Lilly
(1)
lung
(1)
M+ A
(1)
Market stats
(1)
MDACC
(1)
MEDI
(1)
Mek
(1)
Merck
(1)
Merrimack
(1)
Met
(2)
MK-0457
(1)
mutations
(1)
new targets
(2)
Nexavar
(5)
NVS
(3)
ONXX
(5)
OSIP
(3)
OSU-03012
(1)
P3
(1)
p38
(4)
Pathways
(1)
PCOP
(1)
PDGFR
(2)
pertuzumab
(2)
PFE
(3)
PI3
(3)
Pim
(1)
PKC
(1)
Plk
(1)
ProIX
(1)
prostate
(1)
RA
(3)
RCC
(3)
Sanofi
(1)
Scios
(1)
SGX
(3)
SGX-523
(2)
SNS-032
(1)
Sprycel
(1)
Src
(1)
Sunesis
(1)
SUPG
(1)
Sutent
(5)
TAK1
(1)
Tarceva
(3)
Targegen
(1)
Targeted therapies
(1)
Tasigna
(1)
thyroid
(1)
Torisel
(1)
trials
(1)
Tykerb
(3)
VEGF
(2)
VEGFR
(1)
VRTX
(1)
VX-680
(1)
WYE
(1)
Wyeth
(1)
Xcovery
(1)
XL518
(1)
XL999
(1)
Feeds
No comments:
Post a Comment